Close
ACHEMA MIDDLE EAST 2026

Cell Therapy Production Automation Set To Be On The Horizon

In a recent move, Multiply Labs and Thermo Fisher Scientific have gone ahead and inked a deal in order to expand their partnership and...

Successful Scale-Up of Cell-Gene Therapy With Platform Tech

It is a well-known fact that the Cell and Gene Therapy platforms involve the most intricate production and delivery requirements if we talk about...

NHS Gives Its Nod To New Endometrial Cancer Immunotherapy

The NHS is all set to come up with groundbreaking immunotherapy that can go on to potentially offer a significant additional time when it...

UK Research On Crohns Disease Treatment For Better Outcomes

Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients with newly diagnosed Crohn’s...

CROs Get To Gain From Automating The Traditional Processes

Big Pharma goes on to drive the demand for contract resource organizations- CROs by way of outsourcing almost 45% of research and development activities....

Biology-Driven AI Makes Its Presence Felt In Drug Discovery

The quite hectic journey so as to bring a single new drug to the market essentially spans a decade as well as costs an...

Clinical Trials Automation: Step Towards Sustainable Pharma

The pharmaceutical sector is looking for certain transformative strategies so as to stay ahead in an era that is marked by fast technological growth...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...